Souzan Sanati Selected Research

Inflammation (Inflammations)

1/2020

Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Souzan Sanati Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2005
12	Neoplasms (Cancer) 01/2024 - 10/2004
5	Pathologic Complete Response 01/2024 - 02/2016
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2019
2	Triple Negative Breast Neoplasms 12/2021 - 01/2020
1	Residual Neoplasm 01/2024
1	Inflammation (Inflammations) 01/2020
1	Extranodal Extension 01/2020
1	Neuroendocrine Carcinoma 01/2019
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019
1	Microsatellite Instability 01/2019
1	Fat Necrosis 01/2018
1	Phyllodes Tumor (Cystosarcoma Phylloides) 01/2016
1	Adenocarcinoma 10/2009
1	Acinar Cell Carcinoma 10/2009
1	Primitive Neuroectodermal Tumors (PNET) 06/2007
1	Pathologic Constriction (Stenosis) 06/2005
1	Wounds and Injuries (Trauma) 03/2005

Drug/Important Bio-Agent (IBA)

5	Anastrozole (Arimidex)FDA LinkGeneric 01/2024 - 04/2017
5	Estrogen ReceptorsIBA 01/2024 - 04/2017
5	Biomarkers (Surrogate Marker)IBA 08/2021 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 04/2017 - 10/2009
2	RNA (Ribonucleic Acid)IBA 01/2024 - 10/2009
2	Cyclin-Dependent Kinase 4IBA 11/2017 - 08/2017
2	palbociclibIBA 11/2017 - 08/2017
2	Goserelin (Zoladex)FDA Link 11/2017 - 08/2017
2	Coloring Agents (Dyes)IBA 06/2007 - 10/2004
1	Fulvestrant (Faslodex)FDA Link 01/2024
1	Phenobarbital (Luminal)FDA Link 01/2024
1	Tumor Biomarkers (Tumor Markers)IBA 08/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 08/2021
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	B7-H1 AntigenIBA 01/2019
1	CateninsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	thymidine kinase 1IBA 11/2017
1	Messenger RNA (mRNA)IBA 11/2017
1	Prednisone (Sone)FDA LinkGeneric 11/2017
1	MK 2206IBA 11/2017
1	Estrogens (Estrogen)FDA Link 11/2017
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2017
1	exemestane (Aromasin)FDA Link 04/2017
1	Aromatase InhibitorsIBA 04/2017
1	Letrozole (Femara)FDA LinkGeneric 04/2017
1	ProteomeIBA 01/2017
1	Prolactin Receptors (Prolactin Receptor)IBA 10/2009
1	Periodic AcidIBA 06/2007
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2005
1	Hormones (Hormone)IBA 03/2005

Therapy/Procedure

6	Neoadjuvant Therapy 01/2024 - 02/2016
6	Therapeutics 01/2019 - 01/2016
1	Lymph Node Excision (Lymph Node Dissection) 01/2020
1	Brachytherapy 01/2018
1	Adjuvant Chemotherapy 09/2017
1	Drug Therapy (Chemotherapy) 04/2017
1	Lasers (Laser) 10/2009